Alume Biosciences delivers positive topline results for three pivotal trials of Bevonescein, advancing toward NDA ...
Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.
Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of specific biologic targets—such as enzymes or receptors—by inhibiting or ...
Researchers from the National University of Singapore (NUS) have developed CellScope, a high-performance single-cell analysis ...
Molecular Instruments launches fully ambient-temperature HCR™ Pro RNA-ISH on the BOND-III, marking a new generation of clinical-grade RNA-ISH designed to reduce heat-driven variability, preserve ...
Successful cancer surgery depends on a surgeon’s ability to remove tumors, while minimizing harm to healthy tissues. Surgeons currently use glowing dyes which mark cancer cells to help differentiate ...
Chemists from St. Petersburg University has developed a new family of luminescent iridium complexes that, for the first time, realize a unique mechanism of photoactivated proton transfer. In the ...
Explore five American medtech companies making global impact in 2026 through innovations in surgery, diagnostics, and population health.
Reflecting on the strength of the community and engagement, Dr. Chaubey said, “Symposium 2026 is a living example of turning possibility into reality – a community united by the desire to be among the ...
The human lymphatic system is notoriously difficult to map due to its size and variability among individuals. Spatial ...
Leonard Zon, professor of stem cell and regenerative biology and Grousbeck Professor of Pediatrics at Harvard Medical School, has been awarded the 2026 March of Dimes Richard B. Johnston Jr., MD Prize ...
This study presents a valuable finding on the mutational order for common alterations in colorectal cancer. The evidence of in vitro growth assays comparing mutations is solid, although inclusion of ...